UBS Remains a Buy on Ovintiv (OVV)
In a report released today, Josh Silverstein from UBS maintained a Buy rating on Ovintiv, with a price target of $69.00.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Silverstein is a 5-star analyst with an average return of 11.4% and a 65.38% success rate. Silverstein covers the Energy sector, focusing on stocks such as Ovintiv, APA, and Devon Energy.
In addition to UBS, Ovintiv also received a Buy from Siebert Williams Shank & Co’s Gabriele Sorbara in a report issued on February 27. However, on February 25, TipRanks – Anthropic reiterated a Hold rating on Ovintiv (NYSE: OVV).
Based on Ovintiv’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $2.07 billion and a net profit of $946 million. In comparison, last year the company earned a revenue of $2.19 billion and had a GAAP net loss of $60 million
Based on the recent corporate insider activity of 28 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OVV in relation to earlier this year. Most recently, in December 2025, Gregory Dean Givens, the EVP & COO of OVV sold 50,000.00 shares for a total of $2,016,500.00.
Read More on OVV:
